Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk
Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk
Kain,, Sarah;Croarkin,, Earllaine
2020-07-01 00:00:00
Downloaded from http://journals.lww.com/rehabonc by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/01/2020 RESEARCH ROUND-UP Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk 1 2 Sarah Kain, PT, DPT ; Earllaine Croarkin, PT, MPT 1 2 Clinical Supervisor, Maine Strong Balance Center, Scarborough, ME; and Physical Therapist, Clinical Research Center, National Institutes of Health, Bethesda, MD Cognitive impairment is a common complication for These tests assess multiple cognitive domains. The Clock those with brain tumors. It can occur from direct effects Draw Test is used to identify cognitive impairment, which of a primary brain tumor, metastatic brain tumor, and/or can lead to dementia. There are various methods for scor- 1-3 indirectly from cancer interventions. Depending on tu- ing the Clock Draw Test, one of which is described by 9 9 mor grade, up to 81% of survivors of glioma tumors who Freund et al in 2005. Freund et al use a 7-point scale to have yet to receive intervention can experience cogni- score how accurately one draws clock features. “0” points tive impairment. Cancer-related cognitive impairment in- indicate potentially poor cognitive status, while “7” in- cludes, but is not limited to, deficits in memory, reasoning, dicates excellent cognitive status. Lycke
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngRehabilitation OncologyWolters Kluwer Healthhttp://www.deepdyve.com/lp/wolters-kluwer-health/cognitive-impairment-in-brain-tumor-survivors-emerging-evidence-to-C1TEcYz7gp
Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk
Downloaded from http://journals.lww.com/rehabonc by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/01/2020 RESEARCH ROUND-UP Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk 1 2 Sarah Kain, PT, DPT ; Earllaine Croarkin, PT, MPT 1 2 Clinical Supervisor, Maine Strong Balance Center, Scarborough, ME; and Physical Therapist, Clinical Research Center, National Institutes of Health, Bethesda, MD Cognitive impairment is a common complication for These tests assess multiple cognitive domains. The Clock those with brain tumors. It can occur from direct effects Draw Test is used to identify cognitive impairment, which of a primary brain tumor, metastatic brain tumor, and/or can lead to dementia. There are various methods for scor- 1-3 indirectly from cancer interventions. Depending on tu- ing the Clock Draw Test, one of which is described by 9 9 mor grade, up to 81% of survivors of glioma tumors who Freund et al in 2005. Freund et al use a 7-point scale to have yet to receive intervention can experience cogni- score how accurately one draws clock features. “0” points tive impairment. Cancer-related cognitive impairment in- indicate potentially poor cognitive status, while “7” in- cludes, but is not limited to, deficits in memory, reasoning, dicates excellent cognitive status. Lycke
Journal
Rehabilitation Oncology
– Wolters Kluwer Health
Published: Jul 1, 2020
Recommended Articles
Loading...
References
Treatment of radiation-induced cognitive decline in adult brain tumor patients
Cramer
Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review
Hutchinson
Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey
Zucchella
Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment
van Kessel
The Influence of Cognitive function on balance, mobility, and falls in older cancer survivors
Blackwood
Mild cognitive impairment is associated with falls among older adults: findings from the Irish Longitudinal Study on Ageing (TILDA)
Tyrovolas
A review of cognitive screening tools in cancer
Isenberg-Grzeda
The Mini-Cog as a screen for dementia: validation in a population-based sample
Borson
Drawing clocks and driving cars
Freund
Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment
Lycke
Falls in hospices: a cancer network observational study of fall rates and risk factors
Pearse
Neuropsychological assessment of patients undergoing surgery due to low-grade glioma involving the supplementary motor area
Tymowski
Predictors of health-related quality of life in neurosurgical brain tumor patients: focus on patient-centered perspective
Bunevicius
Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC Brain Cancer Module
Bunevičius
Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients
Bunevičius
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Reijneveld
Surgery for high-grade gliomas in the aging
Konglund
Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination
Brown
Use of the Freund Clock Drawing Test within the Mini-Cog as a screening tool for cognitive impairment in elderly patients with or without cancer
Ketelaars
Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases
Olson
Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life
Olson
Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases
Olson
Exploring the measurement properties of the Montreal Cognitive Assessment in a population of people with cancer
Arcuri
Patient reported feasibility and acceptance of Montreal Cognitive Assessment (MoCA) screening pre- and postoperatively in brain tumour patients
Renovanz
Cognitive screening in brain tumors: short but sensitive enough?
Robinson
The High Sensitivity Cognitive Screen
Fogel
Assessing cognitive function in cancer patients
Vardy
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer
Tchen
Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study
Fan
Cognitive function in breast cancer patients receiving adjuvant chemotherapy
Brezden
Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer
Joly
The relationship between executive function and falls and gait abnormalities in older adults: a systematic review
Kearney
Cognitive contributions to gait and falls: evidence and implications
Amboni
The role of executive function and attention in gait
Yogev-Seligmann
Exploring the roles of central and peripheral nervous system function in gait stability: preliminary insights from cancer survivors
Monfort
Trail Making Test A and B: normative data stratified by age and education
Tombaugh
Share the Full Text of this Article with up to 5 Colleagues for FREE
Sign up for your 14-Day Free Trial Now!
Read and print from thousands of top scholarly journals.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
